Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease.

CONCLUSIONS: There may be positive dose-response predictive effects of FGF23 on all-cause mortality, CVD, and renal events in patients with CKD.
PMID: 28006765 [PubMed - as supplied by publisher]

Source: American Journal of Nephrology - December 22, 2016 Category: Urology & Nephrology Authors: Xue C, Yang B, Zhou C, Dai B, Liu Y, Mao Z, Yu S, Mei C Tags: Am J Nephrol Source Type: research